WER Medical
WER Medical
Topical antiseptic formulations represent a critical frontline defense in advanced wound management, hospital infection control, and consumer trauma recovery. As global health organizations intensify standards to mitigate Healthcare-Associated Infections (HAIs) and combat multi-drug resistant pathogens (such as MRSA and Pseudomonas aeruginosa), the demand for high-efficacy, highly stable, bio-compatible antiseptic ointments has experienced unprecedented growth.
Advanced CDMO & OEM contract synthesis requires exact titration of active pharmaceutical ingredients (APIs)—ranging from Povidone-Iodine (PVP-I) and Chlorhexidine Gluconate (CHG) to broad-spectrum Triple Antibiotics (Bacitracin Zinc, Neomycin, Polymyxin B) and ionic silver complexes.
Producing topicals for breached dermal barriers demands ISO Class 8 (Class 100,000) cleanroom mixing, continuous microbiological monitoring, and closed-loop aseptic homogenization to guarantee zero exogenous contamination.
Modern OEM formulations engineering focuses on thermodynamic phase stability, controlling shear-thinning viscosities, preventing active phase separation, and extending shelf-life across extreme climatic zones (ICH Zone IVb compliance).
Since 2018, WER Medical has specialized in advanced medical wound dressings, focusing on silicone foam variants and bio-active topical contract manufacturing. Our fully automated facilities meet strict FDA, CE MDR, and ISO 13485 standards, ensuring top quality across every production batch. We operate a 10,000㎡ cutting-edge plant in Guangzhou, plus a strategic international sales office in Shenzhen.
Years of R&D in wound care have yielded world-leading products. Our core foaming technology enables safe, comfortable healing; imported raw materials secure quality from the source. With world-class intelligent production lines, the full process—foaming, compounding, gluing, punching, forming, and packaging—delivers superior dressings and topical ointments. We believe medical technology enhances health, relieving patients from pain so all may equally enjoy life’s moments.
Our chemical engineering and pharmaceutical R&D labs offer flexible OEM/ODM formulation development. We match specific anti-microbial spectra with optimized base matrices designed for enhanced dermal penetration, prolonged release, and painless application.
| Active Ingredient Category | Target Active Concentration | Primary Clinical Intent | Base Matrix Delivery System | Regulatory Classification |
|---|---|---|---|---|
| Povidone-Iodine (PVP-I) | 5.0% - 10.0% Concentration | Broad-spectrum microbicidal against bacteria, fungi, spores & viruses | Water-soluble Polyethylene Glycol (PEG) Anhydrous Ointment Base | OTC Monograph / Medical Device Class IIa |
| Triple Antibiotics Formula | Bacitracin (400U), Neomycin (3.5mg), Polymyxin B (5000U) | Prevention of skin infection in minor cuts, scrapes, and post-op sites | White Petrolatum & Mineral Oil Hydrophobic Ointment Base | OTC Drug Monograph / NDA Contract OEM |
| Silver Sulfadiazine / Nano-Silver | 0.5% - 1.0% Active Silver Ion | 2nd & 3rd degree burn wound treatment, severe ulcer anti-bacterial barrier | Hydro-Emulsified Oil-in-Water (O/W) Micro-emulsion Cream/Ointment | CE MDR Class III / Prescription & Hospital Supply |
| Chlorhexidine Gluconate (CHG) | 0.5% - 4.0% Active CHG | Pre-operative skin preparation, central line site protection, persistence antimicrobial | Non-ionic Emulsifying Base / Alcohol-Free Gel-Ointment Hydrogel | FDA / CE Medical Device & Biocidal Product |
| Benzalkonium Chloride + Pain Relief | 0.13% BKC + 2.0% Pramoxine HCl | Dual-action antiseptic anti-microbial with local anesthetic topical relief | Soothing Aloe & Hydro-petrolatum Emulsion Matrix | First-Aid Consumer Retail OTC |
Navigating global healthcare supply chains requires balancing strict regulatory compliance, scale efficiency, cost control, and rapid market entry. Operating from Guangzhou—China’s premier medical manufacturing hub—WER Medical delivers unmatched industrial advantages.
From chemical raw material synthesis and high-purity medical-grade petrolatum sourcing to in-house tube extrusion and sterile secondary pouching, our end-to-end infrastructure eliminates supply disruptions.
Our 10,000㎡ plant features automated vacuum emulsifiers, micro-dosing tube-filling machinery, ultrasonic tail sealing, and robotic cartoning—ensuring unit-to-unit consistency at 100,000+ units per day.
Leveraging China's manufacturing scale allows us to provide highly competitive contract prices without compromising ISO 13485 or FDA cGMP standards, giving brand partners significant gross margin expansion.
The global topical healthcare landscape is shifting from standard petroleum jelly carriers to smart bio-compatible delivery systems. Partnering with WER Medical guarantees access to state-of-the-art technological trends.
Conventional ointments release active agents rapidly upon application, requiring frequent reapplication. Novel OEM formulations utilize liposomal and polymer-encapsulated antimicrobial agents that release sustained micro-doses over 24 to 48 hours, reducing tissue cytotoxicity while maintaining continuous barrier protection.
Modern wound care combines silicone foam dressings, calcium alginate dressings, and customized paraffin or antiseptic ointments. Formulations are now optimized to prevent matrix degradation when used under occlusive exudate-managing silicone foam dressings.
Global healthcare brands demand preservative-free, paraben-free, and non-sensitizing bases. OEM lines are adopting anhydrous petrolatum and hydro-gel platforms that eliminate the need for harsh synthetic preservatives while extending shelf life.
Transitioning from standard plastic tubes to 100% recyclable aluminum tubes, post-consumer recycled (PCR) caps, and biodegradable single-use sachets to fulfill corporate sustainability ESG goals for global medical distribution.
Our custom OEM antiseptic ointments are formulated to meet exact operational environments—from sterile operating rooms and burn trauma units to tactical military kits and consumer pharmacy shelves.
Applied directly to post-operative surgical incisions, catheter entry sites, and tracheostomy wounds to construct a sterile liquid barrier against nosocomial bacterial infection.
Packaged in 15g, 30g, or single-use 0.9g sachets for home first-aid supplies, providing consumer-friendly treatment for minor cuts, abrasions, thermal burns, and insect bites.
Heavy-duty, high-viscosity formulations designed to withstand high storage temperatures (-20°C to +55°C) for tactical combat medical kits and disaster relief operations.
WER Medical is a trusted China-based company of high-quality medical supplies. As a medical dressing and topical ointment enterprise integrating R&D, production, and sales, we provide customers with fully customized services.
When evaluating OEM/ODM ointment manufacturers, procurement directors must verify key technical standards to prevent batch failures, active degradation, or regulatory rejection.
Ensure the factory provides High-Performance Liquid Chromatography (HPLC) assay certification for each batch, guaranteeing active ingredients remain within ±5% of specified concentrations throughout shelf life.
Mandatory validation under USP <51> or EP 5.1.3 standards to confirm the ointment resists microbial proliferation upon repeated consumer opening and multi-use application.
Verify accelerated stability data (40°C ± 2°C / 75% RH ± 5% RH for 6 months) and long-term stability data (25°C ± 2°C / 60% RH for 24-36 months) to secure regulatory filing approvals.
Answers to common inquiries regarding OEM contract manufacturing, regulatory compliance, custom formulations, packaging, and minimum order quantities (MOQ).
